- Home
- EDSA vs GVP Comparison
EDSA vs GVP Comparison
Compare EDSA & GVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- GVP
- Stock Information
- Founded
- EDSA 2015
- GVP 1994
- Country
- EDSA Canada
- GVP United States
- Employees
- EDSA N/A
- GVP N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- GVP Computer Software: Prepackaged Software
- Sector
- EDSA Health Care
- GVP Technology
- Exchange
- EDSA Nasdaq
- GVP Nasdaq
- Market Cap
- EDSA 13.8M
- GVP 14.2M
- IPO Year
- EDSA N/A
- GVP 1995
- Fundamental
- Price
- EDSA $4.06
- GVP $4.09
- Analyst Decision
- EDSA Strong Buy
- GVP Strong Buy
- Analyst Count
- EDSA 2
- GVP 1
- Target Price
- EDSA $39.00
- GVP $13.00
- AVG Volume (30 Days)
- EDSA 12.3K
- GVP 61.6K
- Earning Date
- EDSA 08-09-2024
- GVP 11-12-2024
- Dividend Yield
- EDSA N/A
- GVP N/A
- EPS Growth
- EDSA N/A
- GVP N/A
- EPS
- EDSA N/A
- GVP N/A
- Revenue
- EDSA N/A
- GVP $44,789,000.00
- Revenue This Year
- EDSA N/A
- GVP $29.76
- Revenue Next Year
- EDSA N/A
- GVP $10.48
- P/E Ratio
- EDSA N/A
- GVP N/A
- Revenue Growth
- EDSA N/A
- GVP N/A
- 52 Week Low
- EDSA $2.50
- GVP $1.21
- 52 Week High
- EDSA $8.33
- GVP $5.38
- Technical
- Relative Strength Index (RSI)
- EDSA 42.54
- GVP 59.80
- Support Level
- EDSA $4.13
- GVP $4.02
- Resistance Level
- EDSA $4.44
- GVP $4.05
- Average True Range (ATR)
- EDSA 0.22
- GVP 0.04
- MACD
- EDSA -0.01
- GVP -0.01
- Stochastic Oscillator
- EDSA 6.90
- GVP 70.00
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About GVP GSE Systems Inc.
GSE Systems Inc is a company engaged in providing engineering, staffing, and simulation software to clients in the power and process industries. It also provides interactive computer-based tutorials and simulation software for the refining, chemical, and petrochemical industries. It functions through two segments: The engineering segment and the Workforce Solutions segment. Its geographical segments include the United States, Europe, and Asia, out of which the majority of the revenue is generated from the United States.